Force-clamp spectroscopy identifies a catch bond mechanism in a Gram-positive pathogen.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
27 10 2020
Historique:
received: 05 05 2020
accepted: 01 10 2020
entrez: 28 10 2020
pubmed: 29 10 2020
medline: 20 11 2020
Statut: epublish

Résumé

Physical forces have profound effects on cellular behavior, physiology, and disease. Perhaps the most intruiguing and fascinating example is the formation of catch-bonds that strengthen cellular adhesion under shear stresses. Today mannose-binding by the Escherichia coli FimH adhesin remains one of the rare microbial catch-bond thoroughly characterized at the molecular level. Here we provide a quantitative demonstration of a catch-bond in living Gram-positive pathogens using force-clamp spectroscopy. We show that the dock, lock, and latch interaction between staphylococcal surface protein SpsD and fibrinogen is strong, and exhibits an unusual catch-slip transition. The bond lifetime first grows with force, but ultimately decreases to behave as a slip bond beyond a critical force (~1 nN) that is orders of magnitude higher than for previously investigated complexes. This catch-bond, never reported for a staphylococcal adhesin, provides the pathogen with a mechanism to tightly control its adhesive function during colonization and infection.

Identifiants

pubmed: 33110079
doi: 10.1038/s41467-020-19216-8
pii: 10.1038/s41467-020-19216-8
pmc: PMC7591895
doi:

Substances chimiques

Adhesins, Bacterial 0
Fibrinogen 9001-32-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5431

Références

Proc Natl Acad Sci U S A. 2018 May 22;115(21):5564-5569
pubmed: 29735708
Phys Chem Chem Phys. 2014 Feb 14;16(6):2211-23
pubmed: 24419646
Science. 2018 Mar 30;359(6383):1527-1533
pubmed: 29599244
Vet Microbiol. 2009 Sep 18;138(3-4):345-52
pubmed: 19372010
Annu Rev Biophys Biomol Struct. 2001;30:105-28
pubmed: 11340054
Nat Commun. 2014 Jun 02;5:3941
pubmed: 24887573
ACS Nano. 2018 Apr 24;12(4):3609-3622
pubmed: 29633832
J Biol Chem. 2008 Apr 25;283(17):11596-605
pubmed: 18292092
Cell. 2003 Oct 17;115(2):217-28
pubmed: 14567919
Nat Protoc. 2014 May;9(5):1049-55
pubmed: 24722404
PLoS Pathog. 2008 Nov;4(11):e1000226
pubmed: 19043557
Cell. 2015 May 21;161(5):988-997
pubmed: 26000479
Nat Rev Microbiol. 2008 Sep;6(9):674-80
pubmed: 18622407
Cell. 2014 Apr 10;157(2):357-368
pubmed: 24725404
Cell. 2010 May 14;141(4):645-55
pubmed: 20478255
Nat Chem Biol. 2009 Jun;5(6):383-90
pubmed: 19448607
J Biol Chem. 2008 Jan 4;283(1):638-47
pubmed: 17991749
Biochemistry. 2017 Jul 25;56(29):3710-3724
pubmed: 28666084
Nature. 2003 May 8;423(6936):190-3
pubmed: 12736689
Methods Mol Biol. 2015;1271:173-85
pubmed: 25697524
Nat Rev Microbiol. 2014 Jan;12(1):49-62
pubmed: 24336184
Angew Chem Int Ed Engl. 2000 Sep 15;39(18):3212-3237
pubmed: 11028062
FEMS Microbiol Rev. 2014 Nov;38(6):1250-70
pubmed: 25212723
J Thromb Haemost. 2017 May;15(5):1009-1019
pubmed: 28182324
Nat Cell Biol. 2017 Jul;19(7):742-751
pubmed: 28628082
PLoS One. 2013 Jun 21;8(6):e66901
pubmed: 23805283
Trends Microbiol. 2018 Aug;26(8):645-648
pubmed: 29866473
Infect Immun. 2015 Oct;83(10):4093-102
pubmed: 26238710
Sci Adv. 2020 Mar 25;6(13):eaay5999
pubmed: 32232150
mBio. 2017 Dec 5;8(6):
pubmed: 29208742
Nat Rev Microbiol. 2020 Apr;18(4):227-240
pubmed: 31959911
Cell. 2002 Jun 28;109(7):913-23
pubmed: 12110187
Mol Microbiol. 2014 Jul;93(2):356-68
pubmed: 24898289
J Am Chem Soc. 2019 Sep 18;141(37):14752-14763
pubmed: 31464132
Science. 2018 Mar 30;359(6383):1464-1465
pubmed: 29599229
Nano Lett. 2015 Nov 11;15(11):7370-6
pubmed: 26259544
Cell Host Microbe. 2008 Oct 16;4(4):314-23
pubmed: 18854236
Infect Immun. 2011 Aug;79(8):3074-86
pubmed: 21576333
Curr Opin Struct Biol. 2020 Feb;60:124-130
pubmed: 32058258
J Struct Biol. 2017 Jan;197(1):50-56
pubmed: 27046010
Annu Rev Biophys. 2008;37:399-416
pubmed: 18573088

Auteurs

Marion Mathelié-Guinlet (M)

Louvain Institute of Biomolecular Science and Technology, UCLouvain, Croix du Sud, 4-5, bte L7.07.07, B-1348, Louvain-la-Neuve, Belgium.

Felipe Viela (F)

Louvain Institute of Biomolecular Science and Technology, UCLouvain, Croix du Sud, 4-5, bte L7.07.07, B-1348, Louvain-la-Neuve, Belgium.

Giampiero Pietrocola (G)

Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, Viale Taramelli 3/b, 27100, Pavia, Italy.

Pietro Speziale (P)

Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, Viale Taramelli 3/b, 27100, Pavia, Italy.

David Alsteens (D)

Louvain Institute of Biomolecular Science and Technology, UCLouvain, Croix du Sud, 4-5, bte L7.07.07, B-1348, Louvain-la-Neuve, Belgium. david.alsteens@uclouvain.be.
Walloon Excellence in Life sciences and Biotechnology (WELBIO), B-1300, Wavre, Belgium. david.alsteens@uclouvain.be.

Yves F Dufrêne (YF)

Louvain Institute of Biomolecular Science and Technology, UCLouvain, Croix du Sud, 4-5, bte L7.07.07, B-1348, Louvain-la-Neuve, Belgium. yves.dufrene@uclouvain.be.
Walloon Excellence in Life sciences and Biotechnology (WELBIO), B-1300, Wavre, Belgium. yves.dufrene@uclouvain.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH